Late Safety and Efficacy of a Zotarolimus-Eluting Stent Compared with a Paclitaxel-Eluting Stent in Patients with De Novo Coronary Lesions: Three-Year Follow-up from the ENDEAVOR IV Trial

被引：0
|
作者：
Leon, Martin B. [1 ]
Mauri, Laura [2 ]
O'Shaughnessy, Charles [3 ]
Ovelie, Paul A. [4 ]
McLaurin, Brent T. [5 ]
Solomon, Stuart L. [6 ]
Ball, Michael [7 ]
Douglas, John S. [8 ]
Cutlip, Donald E. [9 ]
Kandzari, David E. [10 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Brigham & Womens Hosp, Harvard Clin Res Inst, Boston, MA 02115 USA
[3] Elyria Mem Hosp, Elyria, OH USA
[4] Lubbock Heart Hosp, Lubbock, TX USA
[5] Anderson Med Ctr, Anderson, SC USA
[6] Methodist Hosp, Houston, TX 77030 USA
[7] Heart Ctr Indiana, Indianapolis, IN USA
[8] Emory Univ Hosp, Atlanta, GA 30322 USA
[9] Harvard Cardiac Res Inst, Boston, MA USA
[10] Scripps Clin, La Jolla, CA USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2009年 / 104卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：150D / 150D
页数：1
相关论文
共 50 条
  • [31] Clinical and safety outcomes among patients receiving the endeavor zotarolimus-eluting stent: A pooled analysis of endeavor I to IV
    Gershlick, Anthony
    Leon, Martin B.
    Wijns, William
    Meredith, Ian
    Fajadet, Jean
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 146L - 147L
  • [32] A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: Final results of the ZoMaxx II trial
    Gray, William A.
    Yeung, Alan C.
    Cutlip, Donald E.
    Popma, Jeffrey J.
    Fitzgerald, Peter J.
    Williams, David O.
    Heuer, Hubertus
    O'Shaughnessy, Charles D.
    Overlie, Paul A.
    Mann, J. Tift
    Cannon, Louis A.
    Hermiller, James B.
    Henry, Timothy D.
    Whitbourn, Robert
    Stuckey, Thomas D.
    Midei, Mark G.
    Coe, Jessie
    Schwartz, Lewis B.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 157 (01) : 96 - 101
  • [33] COMPARISON OF THE EFFICACY AND SAFETY OF PACLITAXEL-ELUTING COROFLEXTM PLEASE STENT VERSUS PACLITAXEL-ELUTING STENT IN PATIENTS WITH CORONARY ARTERY DISEASE: THE PIPA RANDOMIZED CONTROLLED TRIAL
    Kim, Young-Hak
    Kim, Hyun-Sook
    Park, Duk-Woo
    Cheong, Sang-Sig
    Lee, Bong-Ki
    Lee, Seung-Wook
    Lee, Keun
    Lee, Nae-Hee
    Lee, Sang-Gon
    Lee, Chang Hoon
    Hwang, Ki Won
    Park, Gyung-Min
    Kim, Yong-Giun
    Ahn, Jung-Min
    Song, Hae Geun
    Kim, Won-Jang
    Lee, Jong-Young
    Kang, Soo-Jin
    Lee, Seung-Whan
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1837 - E1837
  • [34] The safety and efficacy of the endeavor zotarolimus-eluting stent system in Japanese patients with symptomatic coronary artery disease: ENDEAVOR Japan at 9 months
    Sato, Shigeru
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 161L - 161L
  • [35] An Evaluation of a Sirolimus-Eluting Bioadaptor as Compared to a Zotarolimus-Eluting Stent in de Novo Coronary Arteries - "The Bioadaptor RCT Study"
    Saito, Shigeru
    Nef, Holger
    Webster, Mark
    Verheye, Stefan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (15) : S1 - S1
  • [36] Comparison of Everolomus-Eluting Stent vs. Zotarolimus-Eluting Stent in Acute Coronary Syndrome: Clinical Outcomes of 1.5-year Follow-up
    Kim, Song-Yi
    Kang, Dong-Gu
    Hyun, So-Young
    Joo, Seung-Jae
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (8A): : 78A - 79A
  • [37] Final 5-Year Outcomes From the Endeavor Zotarolimus-Eluting Stent Clinical Trial Program
    Kandzari, David E.
    Leon, Martin B.
    Meredith, Ian
    Fajadet, Jean
    Wijns, William
    Mauri, Laura
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (05) : 504 - 512
  • [38] Long-Term Clinical and Economic Analysis of the Endeavor Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent 3-Year Results From the ENDEAVOR III Trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)
    Eisenstein, Eric L.
    Leon, Martin B.
    Kandzari, David E.
    Mauri, Laura
    Edwards, Rex
    Kong, David F.
    Cowper, Patricia A.
    Anstrom, Kevin J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) : 1199 - 1207
  • [39] Comparison of the Efficacy and Safety of Paclitaxel-Eluting CoroflexTM Please Stent versus Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease: The PIPA Randomized Controlled Trial.
    Ahn, Jung-Min
    Kim, Young-Hak
    Kim, Hyun-Sook
    Park, Duk-Woo
    Cheong, Sang-Sig
    Lee, Bong-Ki
    Lee, Seung-Wook
    Lee, Keun
    Lee, Nae-Hee
    Lee, Sang-Gon
    Lee, Chang Hoon
    Park, Gyung-Min
    Kim, Yong-Giun
    Hwang, Ki Won
    Lee, Seung-Whan
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (8A): : 20A - 20A
  • [40] BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial
    Chang, Chun Chin
    Kogame, Norihiro
    Asano, Taku
    von Birgelen, Clemens
    Sabate, Manel
    Onuma, Yoshinobu
    Serruys, Patrick W.
    EUROINTERVENTION, 2020, 16 (11) : E900 - E903
12345